Free Trial

Veru (VERU) Competitors

Veru logo
$2.37 +0.05 (+2.16%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$2.36 -0.01 (-0.42%)
As of 05/29/2026 06:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VERU vs. EL, IPAR, PBH, HLF, and NATR

Should you buy Veru stock or one of its competitors? MarketBeat compares Veru with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Veru include Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), and Nature's Sunshine Products (NATR). These companies are all part of the "personal products" industry.

How does Veru compare to Estee Lauder Companies?

Veru (NASDAQ:VERU) and Estee Lauder Companies (NYSE:EL) are both personal products companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Veru has higher earnings, but lower revenue than Estee Lauder Companies. Estee Lauder Companies is trading at a lower price-to-earnings ratio than Veru, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M2.25-$22.73M-$0.89N/A
Estee Lauder Companies$14.83B2.17-$1.13B-$0.70N/A

In the previous week, Estee Lauder Companies had 6 more articles in the media than Veru. MarketBeat recorded 8 mentions for Estee Lauder Companies and 2 mentions for Veru. Veru's average media sentiment score of 1.42 beat Estee Lauder Companies' score of 1.29 indicating that Veru is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Estee Lauder Companies
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Veru has a beta of -1.19, indicating that its share price is 219% less volatile than the broader market. Comparatively, Estee Lauder Companies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

Veru presently has a consensus target price of $23.00, suggesting a potential upside of 870.46%. Estee Lauder Companies has a consensus target price of $101.63, suggesting a potential upside of 14.07%. Given Veru's higher probable upside, equities analysts clearly believe Veru is more favorable than Estee Lauder Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Estee Lauder Companies
2 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.52

47.2% of Veru shares are held by institutional investors. Comparatively, 55.2% of Estee Lauder Companies shares are held by institutional investors. 14.2% of Veru shares are held by company insiders. Comparatively, 13.1% of Estee Lauder Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Veru has a net margin of 0.00% compared to Estee Lauder Companies' net margin of -1.67%. Estee Lauder Companies' return on equity of 20.66% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -54.72% -39.09%
Estee Lauder Companies -1.67%20.66%4.15%

Summary

Estee Lauder Companies beats Veru on 10 of the 17 factors compared between the two stocks.

How does Veru compare to Interparfums?

Veru (NASDAQ:VERU) and Interparfums (NASDAQ:IPAR) are both personal products companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Interparfums has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M2.25-$22.73M-$0.89N/A
Interparfums$1.49B2.03$168.39M$5.2717.91

Veru presently has a consensus price target of $23.00, indicating a potential upside of 870.46%. Interparfums has a consensus price target of $105.20, indicating a potential upside of 11.48%. Given Veru's higher possible upside, equities analysts plainly believe Veru is more favorable than Interparfums.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Interparfums
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71

Interparfums has a net margin of 11.32% compared to Veru's net margin of 0.00%. Interparfums' return on equity of 15.47% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -54.72% -39.09%
Interparfums 11.32%15.47%10.82%

In the previous week, Veru and Veru both had 2 articles in the media. Veru's average media sentiment score of 1.42 beat Interparfums' score of 1.34 indicating that Veru is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Interparfums
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Veru has a beta of -1.19, suggesting that its share price is 219% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market.

47.2% of Veru shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 14.2% of Veru shares are owned by company insiders. Comparatively, 43.7% of Interparfums shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Interparfums beats Veru on 12 of the 15 factors compared between the two stocks.

How does Veru compare to Prestige Consumer Healthcare?

Prestige Consumer Healthcare (NYSE:PBH) and Veru (NASDAQ:VERU) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

In the previous week, Prestige Consumer Healthcare had 4 more articles in the media than Veru. MarketBeat recorded 6 mentions for Prestige Consumer Healthcare and 2 mentions for Veru. Veru's average media sentiment score of 1.42 beat Prestige Consumer Healthcare's score of 0.65 indicating that Veru is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prestige Consumer Healthcare
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Veru
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 1.4% of Prestige Consumer Healthcare shares are owned by insiders. Comparatively, 14.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Prestige Consumer Healthcare has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, Veru has a beta of -1.19, meaning that its share price is 219% less volatile than the broader market.

Prestige Consumer Healthcare has a net margin of 17.48% compared to Veru's net margin of 0.00%. Prestige Consumer Healthcare's return on equity of 11.54% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare17.48% 11.54% 6.16%
Veru N/A -54.72%-39.09%

Prestige Consumer Healthcare has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prestige Consumer Healthcare$1.09B2.07$190.30M$3.9112.15
Veru$16.89M2.25-$22.73M-$0.89N/A

Prestige Consumer Healthcare currently has a consensus target price of $70.75, suggesting a potential upside of 48.87%. Veru has a consensus target price of $23.00, suggesting a potential upside of 870.46%. Given Veru's stronger consensus rating and higher possible upside, analysts clearly believe Veru is more favorable than Prestige Consumer Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prestige Consumer Healthcare
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Prestige Consumer Healthcare beats Veru on 10 of the 16 factors compared between the two stocks.

How does Veru compare to Herbalife?

Herbalife (NYSE:HLF) and Veru (NASDAQ:VERU) are both small-cap personal products companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

Herbalife has a net margin of 4.67% compared to Veru's net margin of 0.00%. Herbalife's return on equity of -41.47% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Herbalife4.67% -41.47% 8.24%
Veru N/A -54.72%-39.09%

Herbalife has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Herbalife, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Herbalife$5.04B0.25$228.30M$2.285.23
Veru$16.89M2.25-$22.73M-$0.89N/A

Herbalife currently has a consensus price target of $17.80, suggesting a potential upside of 49.24%. Veru has a consensus price target of $23.00, suggesting a potential upside of 870.46%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than Herbalife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Herbalife
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Herbalife and Herbalife both had 2 articles in the media. Veru's average media sentiment score of 1.42 beat Herbalife's score of 1.00 indicating that Veru is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Herbalife
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Veru
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Herbalife has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, Veru has a beta of -1.19, indicating that its stock price is 219% less volatile than the broader market.

47.2% of Veru shares are owned by institutional investors. 5.1% of Herbalife shares are owned by company insiders. Comparatively, 14.2% of Veru shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Herbalife beats Veru on 8 of the 14 factors compared between the two stocks.

How does Veru compare to Nature's Sunshine Products?

Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations.

47.2% of Veru shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 14.2% of Veru shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Nature's Sunshine Products has a net margin of 4.06% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 14.67% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -54.72% -39.09%
Nature's Sunshine Products 4.06%14.67%9.27%

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M2.25-$22.73M-$0.89N/A
Nature's Sunshine Products$489.79M0.76$19.52M$1.1019.35

Veru has a beta of -1.19, indicating that its share price is 219% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market.

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 2 mentions for Veru. Veru's average media sentiment score of 1.42 beat Nature's Sunshine Products' score of 1.40 indicating that Veru is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Veru presently has a consensus price target of $23.00, suggesting a potential upside of 870.46%. Nature's Sunshine Products has a consensus price target of $35.00, suggesting a potential upside of 64.47%. Given Veru's higher possible upside, analysts plainly believe Veru is more favorable than Nature's Sunshine Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Nature's Sunshine Products beats Veru on 11 of the 15 factors compared between the two stocks.

Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$37.24M$8.29B$6.45B$12.61B
Dividend YieldN/A2.53%2.69%5.24%
P/E Ratio-2.6616.1221.4026.28
Price / Sales2.258.36530.7894.67
Price / CashN/A17.4343.6557.38
Price / Book1.094.0910.607.32
Net Income-$22.73M$224.05M$3.56B$337.27M
7 Day Performance0.85%3.72%2.85%3.57%
1 Month Performance5.33%4.14%4.58%5.71%
1 Year Performance-53.52%3.90%37.67%39.75%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
2.6846 of 5 stars
$2.37
+2.2%
$23.00
+870.5%
-53.5%$37.24M$16.89MN/A230
EL
Estee Lauder Companies
4.7801 of 5 stars
$80.00
-0.4%
$100.68
+25.9%
+29.6%$29.04B$14.33BN/A57,000
IPAR
Interparfums
3.9801 of 5 stars
$87.36
+1.4%
$105.20
+20.4%
-30.1%$2.76B$1.49B16.58530
PBH
Prestige Consumer Healthcare
4.357 of 5 stars
$46.61
-0.3%
$70.75
+51.8%
-43.7%$2.21B$1.09B11.92540
HLF
Herbalife
4.7303 of 5 stars
$12.59
-1.9%
$17.80
+41.4%
+50.5%$1.33B$5.04B5.528,500

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners